6/17
01:00 am
moln
Molecular Partners to Present at The TD Cowen Radiopharmaceutical Innovation Summit
High
Report
Molecular Partners to Present at The TD Cowen Radiopharmaceutical Innovation Summit
6/14
01:05 am
moln
Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EHA 2024 [Yahoo! Finance]
High
Report
Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EHA 2024 [Yahoo! Finance]
6/14
01:00 am
moln
Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EHA 2024
High
Report
Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EHA 2024
6/11
01:09 am
moln
Molecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPin Therapy (RDT) Candidate MP0712 at SNMMI 2024 [Yahoo! Finance]
High
Report
Molecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPin Therapy (RDT) Candidate MP0712 at SNMMI 2024 [Yahoo! Finance]
6/11
01:00 am
moln
Molecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPin Therapy (RDT) Candidate MP0712 at SNMMI 2024
High
Report
Molecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPin Therapy (RDT) Candidate MP0712 at SNMMI 2024
6/1
08:19 am
moln
Molecular Partners Presents Positive Data From Completed Phase 1 Trial Of MP0317 (FAP X CD40 DARPin) Monotherapy In Patients With Advanced Solid Tumors At ASCO 2024 [Yahoo! Finance]
Low
Report
Molecular Partners Presents Positive Data From Completed Phase 1 Trial Of MP0317 (FAP X CD40 DARPin) Monotherapy In Patients With Advanced Solid Tumors At ASCO 2024 [Yahoo! Finance]
6/1
08:00 am
moln
Molecular Partners Presents Positive Data From Completed Phase 1 Trial Of MP0317 (FAP X CD40 DARPin) Monotherapy In Patients With Advanced Solid Tumors At ASCO 2024
Low
Report
Molecular Partners Presents Positive Data From Completed Phase 1 Trial Of MP0317 (FAP X CD40 DARPin) Monotherapy In Patients With Advanced Solid Tumors At ASCO 2024
5/31
05:01 am
moln
Global Tetraspecific Antibodies Clinical Trials & Market Report 2024: Pioneering the Future of Cancer Treatment, Shift Towards Tetraspecific Antibodies Amidst Drug Resistance Challenges [Yahoo! Finance]
High
Report
Global Tetraspecific Antibodies Clinical Trials & Market Report 2024: Pioneering the Future of Cancer Treatment, Shift Towards Tetraspecific Antibodies Amidst Drug Resistance Challenges [Yahoo! Finance]
5/30
04:54 am
moln
Molecular Partners AG's (VTX:MOLN) top owners are individual investors with 38% stake, while 38% is held by hedge funds [Yahoo! Finance]
Medium
Report
Molecular Partners AG's (VTX:MOLN) top owners are individual investors with 38% stake, while 38% is held by hedge funds [Yahoo! Finance]
5/22
09:37 am
moln
"EMBRACING INTERNATIONAL ALLIANCES" SWISS BIOTECH INNOVATION ON DISPLAY AT THE BIO 2024 INTERNATIONAL CONVENTION IN SAN DIEGO JUNE 3-6, 2024 [Yahoo! Finance]
Medium
Report
"EMBRACING INTERNATIONAL ALLIANCES" SWISS BIOTECH INNOVATION ON DISPLAY AT THE BIO 2024 INTERNATIONAL CONVENTION IN SAN DIEGO JUNE 3-6, 2024 [Yahoo! Finance]
5/16
04:06 pm
moln
Interim Management Statement Q1 2024 of Molecular Partners: Pipeline Progressing with Two Additional Programs to Enter the Clinic in 2025, Update to MP0533 Program [Yahoo! Finance]
Low
Report
Interim Management Statement Q1 2024 of Molecular Partners: Pipeline Progressing with Two Additional Programs to Enter the Clinic in 2025, Update to MP0533 Program [Yahoo! Finance]
5/16
04:00 pm
moln
Interim Management Statement Q1 2024 of Molecular Partners: Pipeline Progressing with Two Additional Programs to Enter the Clinic in 2025, Update to MP0533 Program
Low
Report
Interim Management Statement Q1 2024 of Molecular Partners: Pipeline Progressing with Two Additional Programs to Enter the Clinic in 2025, Update to MP0533 Program
4/29
11:10 am
moln
Molecular Partners Announces Publication in Cancer Immunology Research of Preclinical Data Supporting MP0533's Proposed Mechanism of Action [Yahoo! Finance]
Low
Report
Molecular Partners Announces Publication in Cancer Immunology Research of Preclinical Data Supporting MP0533's Proposed Mechanism of Action [Yahoo! Finance]
4/29
11:00 am
moln
Molecular Partners Announces Publication in Cancer Immunology Research of Preclinical Data Supporting MP0533’s Proposed Mechanism of Action
Low
Report
Molecular Partners Announces Publication in Cancer Immunology Research of Preclinical Data Supporting MP0533’s Proposed Mechanism of Action
4/19
11:24 am
moln
Life Science Cares Launches in Switzerland [Yahoo! Finance]
Neutral
Report
Life Science Cares Launches in Switzerland [Yahoo! Finance]
4/19
11:12 am
moln
Life Science Cares Launches in Switzerland
Medium
Report
Life Science Cares Launches in Switzerland
4/18
01:50 am
moln
We Think Molecular Partners (VTX:MOLN) Needs To Drive Business Growth Carefully [Yahoo! Finance]
Low
Report
We Think Molecular Partners (VTX:MOLN) Needs To Drive Business Growth Carefully [Yahoo! Finance]
4/17
11:12 am
moln
Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting
Neutral
Report
Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting
3/26
09:26 am
moln
Molecular Partners Publishes Invitation to Annual General Meeting 2024
Neutral
Report
Molecular Partners Publishes Invitation to Annual General Meeting 2024